Viral-associated cancers and disorders
Viral-associated cancers and disorders is a research topic within Oncology. Science Explorer counts 34k research works in it since 1951. 17.5% of them reached the world's top 10% most cited for their field and year.
This cluster of papers focuses on the incidence, risk factors, and management of viral-related cancers, particularly associated with Epstein-Barr virus (EBV) and Kaposi's Sarcoma-associated herpesvirus (KSHV), in immunocompromised individuals such as HIV/AIDS patients and transplant recipients. It explores the impact of immunosuppression, antiretroviral therapy, and viral reactivation on cancer development, as well as the use of targeted therapies and immune-based treatments for these malignancies.
- Epstein-Barr Virus
- Kaposi's Sarcoma
- HIV/AIDS
- Transplant Recipients
- Lymphoproliferative Disorders
- Human Herpesvirus 8
- Cancer Incidence
- Immunosuppression
- Post-Transplant Lymphoproliferative Disease
- Viral Oncogenesis
- Research works
- 34k fractional, since 1951
- In the world top 10%
- 5.9k per year above
- Top-10% rate
- 17.5% share of its works in the world top 10%
- Growth, 2013–17 → 2018–22
- +12% the tick is no change
This ranks research output and citation impact. It says nothing about the quality of diagnosis, treatment or care.
Which countries lead Viral-associated cancers and disorders research?
By volume, the United States and China publish the most (1.3k and 900 works in 2022–2025).
By volume, 2022–2025
- 1 United States 1.3k works
- 2 China 900 works
- 3 Japan 303 works
- 4 India 192 works
- 5 Italy 157 works
- 6 Brazil 150 works
- 7 France 136 works
- 8 Germany 117 works
- 9 United Kingdom 115 works
- 10 Spain 105 works
How concentrated that is
The same countries as shares of everything the list above accounts for. A node where two countries do two thirds of the work and one spread evenly across twelve read alike as a ranking and not at all alike here.
Shares of the rows listed above, not of the whole node.
Which institutions lead Viral-associated cancers and disorders research?
By volume in 2022–2025, The University of Texas MD Anderson Cancer Center publishes the most Viral-associated cancers and disorders research, followed by Sun Yat-sen University and University of North Carolina at Chapel Hill.
By volume, 2022–2025
- 1 The University of Texas MD Anderson Cancer CenterUnited States 32 works
- 2 Sun Yat-sen UniversityChina 29 works
- 3 University of North Carolina at Chapel HillUnited States 28 works
- 4 Chinese Academy of Medical Sciences & Peking Union Medical CollegeChina 24 works
- 5 University of PennsylvaniaUnited States 22 works
- 6 Sun Yat-sen University Cancer CenterChina 21 works
- 7 Sichuan UniversityChina 18 works
- 8 University of California, San FranciscoUnited States 16 works
- 9 Capital Medical UniversityChina 15 works
- 10 National Cancer InstituteUnited States 14 works
Who are the leading researchers in Viral-associated cancers and disorders?
The most-cited researchers publishing on Viral-associated cancers and disorders include Matthew Meyerson.
- 1 Matthew Meyerson United States 4.2k citations
Ranked by citations received across their whole record, among researchers with at least three works on this topic.
Where is Viral-associated cancers and disorders research done?
The largest centres of Viral-associated cancers and disorders research in 2022–2025 are Beijing (China), Guangzhou (China), Tokyo (Japan) and Shanghai (China). Among places with at least 20 works in it, it is an unusually large share of all research in Bethesda and Tampa.
Largest cities, 2022–2025
Where it is the local speciality
- BethesdaUS · 37.2 works6.7×
- TampaUS · 20.2 works6.4×
Location quotient: how much more of its research is in Viral-associated cancers and disorders than the world average.
Where is the best place to study Viral-associated cancers and disorders?
Among universities, judged by research, Sun Yat-sen University, University of Pennsylvania and Chinese Academy of Medical Sciences & Peking Union Medical College score highest, combining excellence, specialisation, size, growth and international reach. Research strength is one signal when choosing where to study; it does not measure teaching.
One dot per university in the table below. The upper left is the interesting corner: small places doing unusually strong work.
| # | University | Score | Top 10% | Specialisation | Works | Growth |
|---|---|---|---|---|---|---|
| 1 | Sun Yat-sen UniversityChina | 60.9 | 30.5% | 4.0× | 29 | +32.4% |
| 2 | University of PennsylvaniaUnited States | 49.6 | 19.1% | 5.3× | 22 | +7.7% |
| 3 | Chinese Academy of Medical Sciences & Peking Union Medical CollegeChina | 48.5 | 13.2% | 5.5× | 24 | +55.4% |
| 4 | Harvard UniversityUnited States | 47.9 | 32.9% | 2.1× | 12 | -6.8% |
| 5 | Nanjing Medical UniversityChina | 43.2 | 18.6% | 4.8× | 11 | +103.0% |
| 6 | University of California, San FranciscoUnited States | 42.6 | 17.4% | 5.5× | 16 | -11.6% |
| 7 | Cornell UniversityUnited States | 41.5 | 21.7% | 3.1× | 14 | +17.5% |
| 8 | Capital Medical UniversityChina | 40.3 | 8.6% | 6.0× | 15 | +72.6% |
| 9 | University of Wisconsin–MadisonUnited States | 37.9 | 30.6% | 2.4× | 10 | -10.3% |
| 10 | Sichuan UniversityChina | 37.8 | 14.4% | 2.3× | 18 | +79.3% |
Universities only. Score blends excellence (30%), specialisation (25%), size (20%), growth (15%) and international reach (10%), 2015–2022; growth compares 2010–14 with 2015–19.
Is Viral-associated cancers and disorders research growing?
Output in 2018–2022 was 12% higher than in 2013–2017, peaking in 2025. The fastest-growing topics are Viral-associated cancers and disorders.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Which topics inside it are moving
Growth and decline on one axis around a shared zero. Two lists side by side hide the thing that matters: whether the growth dwarfs the decline, or the other way round.